vs
Health Catalyst, Inc.(HCAT)与KINGSWAY FINANCIAL SERVICES INC(KFS)财务数据对比。点击上方公司名可切换其他公司
Health Catalyst, Inc.的季度营收约是KINGSWAY FINANCIAL SERVICES INC的1.9倍($74.7M vs $38.6M),KINGSWAY FINANCIAL SERVICES INC净利率更高(-4.1% vs -121.9%,领先117.8%),KINGSWAY FINANCIAL SERVICES INC同比增速更快(30.1% vs -6.2%),过去两年KINGSWAY FINANCIAL SERVICES INC的营收复合增速更高(21.4% vs -0.0%)
Catalyst制药公司是一家总部位于美国佛罗里达州科勒尔盖布尔斯的生物制药企业,专注于开发罕见病治疗药物。其开发的阿米夫斯汀磷酸盐商品名为Firdapse,原本已获FDA批准用于成人兰伯特-伊顿肌无力综合征(LEMS)的治疗,2018年11月又获批可用于6岁及以上儿童LEMS患者。
金斯威金融服务公司是一家专业金融控股企业,主要提供财产和意外伤害保险产品,包括个人车险、商业责任险、财产险等,核心市场覆盖北美地区,服务个人消费者、小微企业主及特定商业客户群体。
HCAT vs KFS — 直观对比
营收规模更大
HCAT
是对方的1.9倍
$38.6M
营收增速更快
KFS
高出36.3%
-6.2%
净利率更高
KFS
高出117.8%
-121.9%
两年增速更快
KFS
近两年复合增速
-0.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $74.7M | $38.6M |
| 净利润 | $-91.0M | $-1.6M |
| 毛利率 | — | — |
| 营业利润率 | -115.3% | 0.8% |
| 净利率 | -121.9% | -4.1% |
| 营收同比 | -6.2% | 30.1% |
| 净利润同比 | -340.3% | -7.8% |
| 每股收益(稀释后) | $-1.29 | $-0.07 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
HCAT
KFS
| Q4 25 | $74.7M | $38.6M | ||
| Q3 25 | $76.3M | $37.2M | ||
| Q2 25 | $80.7M | $30.9M | ||
| Q1 25 | $79.4M | $28.3M | ||
| Q4 24 | $79.6M | $29.6M | ||
| Q3 24 | $76.4M | $27.1M | ||
| Q2 24 | $75.9M | $26.4M | ||
| Q1 24 | $74.7M | $26.2M |
净利润
HCAT
KFS
| Q4 25 | $-91.0M | $-1.6M | ||
| Q3 25 | $-22.2M | $-2.4M | ||
| Q2 25 | $-41.0M | $-3.2M | ||
| Q1 25 | $-23.7M | $-3.1M | ||
| Q4 24 | $-20.7M | $-1.5M | ||
| Q3 24 | $-14.7M | $-2.3M | ||
| Q2 24 | $-13.5M | $-2.2M | ||
| Q1 24 | $-20.6M | $-2.3M |
毛利率
HCAT
KFS
| Q4 25 | — | — | ||
| Q3 25 | 52.6% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 47.5% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
营业利润率
HCAT
KFS
| Q4 25 | -115.3% | 0.8% | ||
| Q3 25 | -22.9% | -2.3% | ||
| Q2 25 | -46.0% | -3.6% | ||
| Q1 25 | -25.4% | -2.5% | ||
| Q4 24 | -22.0% | 6.5% | ||
| Q3 24 | -17.9% | -2.5% | ||
| Q2 24 | -20.8% | 0.5% | ||
| Q1 24 | -30.5% | 2.9% |
净利率
HCAT
KFS
| Q4 25 | -121.9% | -4.1% | ||
| Q3 25 | -29.1% | -6.5% | ||
| Q2 25 | -50.8% | -10.2% | ||
| Q1 25 | -29.9% | -10.9% | ||
| Q4 24 | -26.0% | -5.0% | ||
| Q3 24 | -19.3% | -8.5% | ||
| Q2 24 | -17.8% | -8.3% | ||
| Q1 24 | -27.6% | -8.9% |
每股收益(稀释后)
HCAT
KFS
| Q4 25 | $-1.29 | $-0.07 | ||
| Q3 25 | $-0.32 | $-0.10 | ||
| Q2 25 | $-0.59 | $-0.13 | ||
| Q1 25 | $-0.35 | $-0.13 | ||
| Q4 24 | $-0.33 | $-0.08 | ||
| Q3 24 | $-0.24 | $-0.10 | ||
| Q2 24 | $-0.23 | $-0.08 | ||
| Q1 24 | $-0.35 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $95.7M | $8.5M |
| 总债务越低越好 | $153.3M | $70.7M |
| 股东权益账面价值 | $245.8M | $15.2M |
| 总资产 | $502.6M | $231.5M |
| 负债/权益比越低杠杆越低 | 0.62× | 4.66× |
8季度趋势,按日历期对齐
现金及短期投资
HCAT
KFS
| Q4 25 | $95.7M | $8.5M | ||
| Q3 25 | $91.5M | $9.5M | ||
| Q2 25 | $97.3M | $12.3M | ||
| Q1 25 | $342.0M | $6.5M | ||
| Q4 24 | $392.0M | $5.7M | ||
| Q3 24 | $387.3M | $6.7M | ||
| Q2 24 | $308.3M | $9.8M | ||
| Q1 24 | $327.8M | $12.3M |
总债务
HCAT
KFS
| Q4 25 | $153.3M | $70.7M | ||
| Q3 25 | $153.1M | $70.7M | ||
| Q2 25 | $153.0M | $58.3M | ||
| Q1 25 | $382.9M | $59.5M | ||
| Q4 24 | $382.4M | $57.5M | ||
| Q3 24 | $345.0M | $58.5M | ||
| Q2 24 | — | $47.3M | ||
| Q1 24 | — | $47.1M |
股东权益
HCAT
KFS
| Q4 25 | $245.8M | $15.2M | ||
| Q3 25 | $331.9M | $16.6M | ||
| Q2 25 | $347.5M | $17.4M | ||
| Q1 25 | $376.8M | $5.5M | ||
| Q4 24 | $365.2M | $8.4M | ||
| Q3 24 | $355.0M | $9.9M | ||
| Q2 24 | $357.0M | $20.7M | ||
| Q1 24 | $357.2M | $23.6M |
总资产
HCAT
KFS
| Q4 25 | $502.6M | $231.5M | ||
| Q3 25 | $587.1M | $235.1M | ||
| Q2 25 | $616.2M | $207.7M | ||
| Q1 25 | $891.5M | $192.1M | ||
| Q4 24 | $858.9M | $186.6M | ||
| Q3 24 | $813.0M | $191.1M | ||
| Q2 24 | $691.7M | $192.3M | ||
| Q1 24 | $695.1M | $198.0M |
负债/权益比
HCAT
KFS
| Q4 25 | 0.62× | 4.66× | ||
| Q3 25 | 0.46× | 4.25× | ||
| Q2 25 | 0.44× | 3.34× | ||
| Q1 25 | 1.02× | 10.91× | ||
| Q4 24 | 1.05× | 6.84× | ||
| Q3 24 | 0.97× | 5.88× | ||
| Q2 24 | — | 2.29× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $9.9M | $-3.0K |
| 自由现金流经营现金流 - 资本支出 | $9.6M | — |
| 自由现金流率自由现金流/营收 | 12.9% | — |
| 资本支出强度资本支出/营收 | 0.4% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-697.0K | — |
8季度趋势,按日历期对齐
经营现金流
HCAT
KFS
| Q4 25 | $9.9M | $-3.0K | ||
| Q3 25 | $-464.0K | $1.5M | ||
| Q2 25 | $-9.0M | $337.0K | ||
| Q1 25 | $280.0K | $-1.8M | ||
| Q4 24 | $-3.5M | $1.1M | ||
| Q3 24 | $6.2M | $368.0K | ||
| Q2 24 | $1.6M | $557.0K | ||
| Q1 24 | $10.3M | $249.0K |
自由现金流
HCAT
KFS
| Q4 25 | $9.6M | — | ||
| Q3 25 | $-719.0K | $1.3M | ||
| Q2 25 | $-9.2M | — | ||
| Q1 25 | $-390.0K | — | ||
| Q4 24 | $-3.9M | — | ||
| Q3 24 | $5.5M | — | ||
| Q2 24 | $1.3M | — | ||
| Q1 24 | $10.1M | — |
自由现金流率
HCAT
KFS
| Q4 25 | 12.9% | — | ||
| Q3 25 | -0.9% | 3.4% | ||
| Q2 25 | -11.4% | — | ||
| Q1 25 | -0.5% | — | ||
| Q4 24 | -4.9% | — | ||
| Q3 24 | 7.2% | — | ||
| Q2 24 | 1.7% | — | ||
| Q1 24 | 13.5% | — |
资本支出强度
HCAT
KFS
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.3% | 0.5% | ||
| Q2 25 | 0.3% | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 0.9% | 0.0% | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | 0.3% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HCAT
| Recurring Technology | $51.9M | 69% |
| Professional Services | $22.8M | 31% |
KFS
| Other | $14.8M | 38% |
| Roundhouse Electric Equipment Co Inc | $9.7M | 25% |
| MLC Plumbing LLC | $5.7M | 15% |
| Systems Products International Incspi | $3.8M | 10% |
| Advanced Plumbing And Drain | $2.9M | 8% |
| Southside Plumbing | $1.7M | 4% |